Realcan Pharmaceutical Group Co., Ltd. (002589.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.17B |
| Enterprise Value | 7.92B |
| P/E Ratio | 327.71 |
| PEG Ratio | -1.26 |
| Price/Sales Ratio | 0.43 |
| Price/Book Ratio | 0.77 |
| Enterprise/Revenue | 0.42 |
| Enterprise/EBITDA | 13.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 7.3B |
| Revenue/Share | 4.82 |
| Gross Profit | 776.06M |
| EBITDA | 360.68M |
| Net Income | 16.07M |
| Diluted EPS | 0.01 |
Balance Sheet
| Total Cash | 5.05B |
| Total Cash/Share | 3.36 |
| Total Debt | 5.01B |
| Total Debt/Equity | 0.94 |
| Current Ratio | 1.1 |
| Book Value Per Share | 3.62 |
Price History
| 52-Week Change | -6.21 |
| 52-Week High | 4.69 |
| 52-Week Low | 2.51 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 3.16 |
Statistics
| Average Volume | 62.96M |
| Shares Outstanding | 1.14B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.01 |
| Trailing Annual Dividend Yield | 0.4 |
| Payout Ratio | 11.23 |
| Last Split Factor | 23:10 |
| Last Split Date | May 15, 2017 |
AD
